Side-by-side comparison of AI visibility scores, market position, and capabilities
New York specialty insurance (NYSE: AIZ) ~$11.5B FY2024 revenue; 180M mobile devices protected, AT&T/T-Mobile/Verizon carrier programs, Connected Living platform competing with Asurion and SquareTrade.
Assurant, Inc. is a New York City-based specialty insurance company — publicly traded on the New York Stock Exchange (NYSE: AIZ) as an S&P 500 Financials component — providing specialty insurance, extended warranties, and financial protection products through three segments: Global Housing (lender-placed homeowners insurance for mortgage servicers, renters insurance, and flood insurance), Global Lifestyle (mobile device protection programs for wireless carriers — AT&T, T-Mobile, Verizon; extended warranties for consumer electronics, appliances, and vehicles), and Global Preneed (life insurance for pre-arranged funeral plans) through approximately 14,000 employees in 21 countries. In fiscal year 2024, Assurant reported revenues of approximately $11.5 billion, with adjusted EBITDA growth driven by strong performance in the mobile device protection and connected living programs embedded in AT&T, T-Mobile, and Verizon wireless service bundles — Assurant's Global Lifestyle segment insures approximately 180 million mobile devices worldwide through carrier-embedded device protection plans that are offered at point-of-sale with wireless service activation. CEO Keith Demmings has focused Assurant's strategy on the Connected Living platform — expanding beyond device repair/replacement protection into smart home device management, tech support services, trade-in programs, and connected device subscriptions that create recurring revenue beyond the per-device insurance premium. Assurant's lender-placed insurance (LPI) business — providing homeowners insurance for mortgage borrowers whose own insurance has lapsed or been cancelled — benefits from rising catastrophe activity (hurricanes, wildfires) that makes voluntary insurance markets unaffordable in high-risk coastal and wildfire-prone areas, increasing the population of mortgage borrowers requiring lender-placed coverage.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.